Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

TARS

Rang în acțiuni #4648
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Preț acțiune
$69.68
Ultima sincronizare: 2026-10-19
Capitalizare de piață
$3.26B
Schimbare (1 zi)
2.36%
Schimbare (1 an)
-2.13%
Țară
US
Tranzacționează Tarsus Pharmaceuticals, Inc. (TARS)

Categorie

Healthcare
Istoricul randamentului dividendelor pentru Tarsus Pharmaceuticals, Inc. (TARS)
Randamentul dividendelor (TTM) pentru Tarsus Pharmaceuticals, Inc. (simbol acțiune: TARS) la data de 2023-12-31 este: 0.00%
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Tarsus Pharmaceuticals, Inc. (TARS) între 2018 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
Randamentele dividendelor (TTM) pentru companii similare sau concurente
Companie Randamentul dividendelor Țara
0.00%
US
0.00%
US
2.17%
AU
0.00%
CH
0.00%
NL